Nomura Quick Note: “Delay for European EPP decision”

Home / Nomura Quick Note: “Delay for European EPP decision”

Nomura Quick Note: “Delay for European EPP decision”

CLINUVEL filed its MAA for afamelanotide 16mg implant on 6 February 2012 for the preventative treatment of the orphan light intolerance disorder erythropoietic protoporphyria (EPP).